In bone marrow transformation assays and mouse model systems, co-expression of Meis1 and HoxA9 together cause aggressive leukemias in mice [167,168] and together can replace the requirement for an active MLL-ENL fusion protein [169]. Here, HOXA9 is linked to leukemia.